PharmaLex

pharmalex.com · Bonn, Germany

PharmaLex is a global provider of specialized consulting and outsourced services for the pharmaceutical, biotech, and medical device industries, focusing on regulatory affairs, pharmacovigilance, quality management, and market access. The company supports clients across the product lifecycle, from development and registration through post‑marketing compliance, by providing expert advisory and managed services. It generates revenue through project-based consulting engagements and long-term outsourcing contracts with life sciences companies and sponsors.

Revenue
$250M - $1B
Employees
1,001 - 5,000
Founded
2012
Headquarters
Bonn, Germany

PharmaLex customers on Arbolus

Total customers 30 26 current · 4 former
Reviews growth 9 new reviews since Apr 2026

Customers who reviewed PharmaLex

Seniority of PharmaLex customers

The largest group of people who reviewed PharmaLex holds C-Suite roles (47%), followed by Director (40%) and Manager (13%).

  • C-Suite 47%
  • Director 40%
  • Manager 13%

Customers sample

Revenue Leader Director NPS 9 Will renew
Operations Ops C-Suite NPS 10 Will renew
Legal Analyst Manager NPS 8

Employer names and spend open once the report publishes.

What 30 Arbolus experts think of PharmaLex

Overall sentiment: Positive

NPS distribution shows 60% Promoters (NPS 9–10), 38% Passives (NPS 7–8), and 2% Detractors (NPS 0–6). Renewal intent is strongly positive among high spend and long-term clients; new and pilot users show more uncertainty. Stickiness is high with over 70% in production for more than a year. The most common themes are satisfaction with reliability, compliance assurance, and scalability.

Tell us when the PharmaLex report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

36 Net Promoter Score, from 30 scored reviews
  • Promoters 13
  • Passives 15
  • Detractors 2

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 64%
  • Will renew 16
  • Undecided 8
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 46% 13 answers
  • Director 78% 9 answers
  • Manager 100% 3 answers
  • 8.6/10 Average score from customers who will renew
  • 7.1/10 Average score from undecided customers
  • 9/10 Average score from customers not renewing

Top alternatives

Most weighed by PharmaLex customers

For people who use PharmaLex

Do you use PharmaLex at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 30 customers of PharmaLex have already contributed

Takes a few minutes. Your identity stays anonymous.